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To study the anti-inflammatory mechanisms of Effect of dexamethasone on glucocorticoids, we have compared the effects of
intratracheal carrageenin (2.5 mg) on control rats carrageenin-induced inflammation
and those in which inflammation was subdued by in the lung prior dexamethasone treatment (10mg/l in
drinking water). Inflammation was maximal 48 h
post-carrageenin. After dexamethasone, carra-
geenin caused tittle inflammation or oedema (wet S.F. Smith,1"CA A. Benjamin, A. Dewar,3
lung (rag), n 6, mean +__ $.E.M.; control, 995 -I- 51; M Sheppard,
4 B. Fox,2 T. Smith, A. Guz and carrageenin + dexamethasone, 1144 + 83; com-
pared with carrageenin alone, 1881 198), but T.D. Tetley
rats had more lung lavage neutrophils than those
given carrageenin alone (PMN 106/lung, mean
_+ S.E.M.; control, 0.055 + 0.003; carrageenin + Departments of 1Medicine and 2Histopathology,
dexamethasone, 8.54 _+ 1.52; compared with car- Charing Cross and Westminster Medical School,
rageenin alone, 6.30 + 1.71). Proteolysis and Fulham Palace Road, London, VV6 8RF; 3Electron
partial inactivation of the anti-inflammatory Microscopy Unit and 4Department of
mediator, lipocortin 1 (Lcl), in carrageenin-instil- Histopathology, Royal Brompton Hospital, Sydney led rats was offset in those also given dexa-
methasone, by increased Lcl levels (intact Lcl Street, London, SW3 6NP, UK
ng/ml lavage fluid, n 4, mean + $.E.M.; control
24 + 6; carrageenin 15 + 4; carrageenin + dexa-
methasone, 40 + 15). Maintenance of sufficient CCorresponding Author
intact (fully active) extracellular Lcl may con-
tribute to the actions of glucocorticoids.
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Introduction for example by altering the expression of their
receptors.
5
Inflammation is a complex response to tissue Lipocortin 1 (Lcl), a member of the annexin
damage, often due to microbial invasion, in- family,
6 is glucorticoid-inducible in vivo-9 and
voMng the release and interactions of many has anti-inflammatory activity,
1 expression of
mediators including cYlokines proteinases, which is thought to require binding of Lcl to
eicosanoids and oxidants from resident and specific sites on cell surfaces.
11 It is normally
newly infiltrating cells. It is a particularly im- present in the lung, both intracellularly, in a
portant defensive mechanism in the airways variety of different cell types
2 and extracellularly,
13 14 and lungs, which are constantly exposed to in the epithelial lining fluid.’ Glucocorticoids
inhaled biological, chemical and physical increase the concentrations of Lcl in a variety of
insults, lung cells, including alveolar epithelial cells15 and
16 The endogenous mechanisms regulating alveolar macrophages, and may promote its
inflammation in the lung and in other tissues release onto the cell surface and/or into epithe-
are incompletely understood. However, studies lial lining fluid13’17’ where it would be available
on rodents have shown that prior surgical or for receptor binding. Thus, Lcl could play a
chemical adrenalectomy exacerbates the inflam- pivotal role in the anti-inflammatory actions of
matory response to any given stimulus,2’3 an glucocorticoids in the lung, but currently its con-
effect which can be ameliorated by gluco- tfibutionis unclear.
corticoid replacement therapy, indicating that In this paper, we describe a model of carra-
physiological levels of endogenous circulating geenin-induced pneumonitis which we have char-
glucocorticoid normally regulate inflammatory acterized in control animals and in those in
processes. Glucocorticoids operate via specific which the inflammatory response was subdued
receptors at the transcriptional level to alter the by prior and concurrent treatment with exogen-
expression and activities of specific gene pro- ous glucocorticoid. We have also quantified
ducts (reviewed in Reference 4). They may also extracellular Lcl to assess its putative contribu-
exert indirect effects on inflammatory mediators, tion to the actions of dexamethasone.
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Materials and Methods
Experimental model ofinflammation:
Animals. Groups of mature CFY rats, bred in-
house and weighing between 180 and 220g at
the beginning of the experiment, were housed in
pairs and given unlimited access to food and
(d) Dexamethasone (DEX). These animals were
used to determine the effect of dexamethasone
on the normal lung over the entire time course
of the experiment. They received the same dose
of oral dexamethasone for the same length of
time (96 h) as the CARR+DEX treated rats, but
were not exposed to carrageenin.
water or water containing dexamethasone (see (e) Baseline dexamethasone (BASE DEX). These
animals were needed to establish the effect of below). At the end of the appropriate experi-
mental period, all animals were anaesthetized dexamethasone pretreatment on the lungs of rats
with halothane then sacrificed by sodium thio- in the CARR+ DEX experimental group prior to
pentone overdose, carrageenin administration. Thus, they were
dosed with dexamethasone for 48h then sacri-
Carrageenin treatment. Animals undergoing car- riced as described above.
rageenin instillation were lightly anaesthetized
with halothane and 2.5mg carrageenin/0.5ml Pilot studies. As well as the carrageenin dosing
sterile 0.15M NaCl (lambda-carrageenin (Type regimen and the experimental time course
IV), Sigma Chemical Co., Poole, UK)was instilled described above, we performed pilot studies to
into the lung via the trachea using a previously assess the degree of pneumonitis in animals
described method,9 except that the suspension killed (a) 48 h after a high intratracheal (i.t.) dose
was instilled through a flexible 3FG catheter of carrageenin (5mg/0.5ml NaCl i.t.); (b)4h
(Portex Ltd.) which was introduced through the after the standard dose of carrageenin (2.5 mg/
mouth and between the vocal cords. 0.5 ml NaC1 i.t.); and (c) 96 h after the standard
dose of carrageenin. Inflammation was assessed
Dexamethasone treatment. Dexamethasone by histopathological examination. (dexamethasone sodium phosphate, David Bull
Laboratories, Warwick, UK) was administered in Assessment of the inflammatory response to car-
drinking water at a dose of 10 mg/1. Average con- rageenin with and without dexamethasone:
sumption of fluid was approximately 10% of
body weight per day. This represented a dose of Light microscopy. At least two animals were
approximately l mg dexamethasone/kg body assigned to each of the experimental groups
weight/day, described above. Following treatment and sacri-
fice according to the protocols described above,
Experimental design. The various experimental the lungs were excised and fully inflated under
groups are described in more detail below, constant pressure (25 cm) with formaldehyde
(a) Controls (CON). Control animals were (4% v/v in phosphate buffered saline) which was
required to illustrate and define the physiological instilled via the trachea. Following fixation, the
norm and were, therefore, entirely untreated, lungs were prepared using standard histological
They were not sham-instilled because the main procedures and stained with haematoxylin and
purpose of the experiment was to establish the eosin. They were examined blind.
effect of dexamethasone on the inflamed lung,
not to establish the contribution of saline to the Bronchoalveolar lavage and venous blood. Four
inflammatory response provoked by carrageenin rats were assigned to each group. Following
instillation, death, the pulmonary circulation was perfused in
(b) Carrageenin (CARR). These animals were situ with 0.15M NaC1 via the right ventricle.
used to determine the effect of carrageenin on When the lungs were free of blood, they were
the lung. Animals were instilled with carrageenin removed from the thoracic cavity and lavaged via
as described above and sacrificed 48 h later, the trachea with 6 x 8 ml portions of 0.15M
(c) Carrageenin and dexamethasone NaCl.19 The recovered lavage fluid was pooled
(CARR+ DEX). This group of rats was used to and the volume recorded, a sample removed for
examine the effect of dexamethasone treatment total cell count and differential cell profile by
on the carrageenin-inflamed lung. The animals Wright-Giemsa staining, then the remaining fluid
received dexamethasone in drinking water for was processed as described previously,
i
48h prior to carrageenin exposure. They were Venous blood samples (0.2ml) were taken
then exposed to intratracheal carrageenin and from each animal for differential white blood cell
continued to receive dexamethasone for a further analysis before the beginning of the experiment,
48 h. At this time, they were sacrificed as describ- at the time of carrageenin instillation and at the
ed above for comparison with rats exposed to time of sacrifice. Smears were made of each
carrageenin alone, blood sample, allowed to air dry and stained with
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Wright-Geimsa stain. The proportion of poly- Analysis of extracellular lipocortin 1 in broncho-
morphonuclear neutrophils (PMN) and mono- alveolar lavage fluid. The acellular broncho-
nuclear cells was determined by light microscopy, alveolar lavage fluid (BALF) samples analysed in
Approximately 150 cells were counted per smear this part of the experiment were those collected
except in dexamethasone-treated animals in as described in a previous section. The cellular
which circulating leukocytes were sparse. Lcl content was not determined in this study.
Extracellular Lcl levels were measured using a
Electron microscoly. The experiment was per- previously described2 competitive enzyme-linked
formed on two rats per treatment group as immunosorbent assay (ELISA) modified as
described for the light microscopy study, except follows. Gelatin (2% w/v) was used as a blocking
that the lungs were inflated with 2% para- agent, wells were coated with 100 l.tl Lcl (1 lg/
formaldehyde and 2.5% glutaraldehyde in 0.1M ml) and the polyclonal anti-Lcl antibody was
sodium cacodylate buffer, pH 7.4. After 24-72 h, used at a dilution of 1:30000 in phosphate buf-
this fixative was replaced with 50mM sodium fered saline containing 0.5% Tween.
cacodylate buffer, pH 7.4, containing 7.5% Samples of BALF were concentrated 7.5-fold
sucrose. The lungs were encoded and stored at by centrifugation in Centricon units with a
4C until prepared for electron microscopy using nominal molecular weight cut-off of 2 000 kDa.
standard techniques. They were examined blind. Concentrates were separated by SDS-poly-
acrylamide gel electrophoresis, followed by
Assessment of oedema by wet and dry lung Western blotting and staining for Lcl as describ-
weight measurements. Animals (six or seven per ed previously.
4 The relative proportions of intact
group) were treated as described above. Follow- and proteolysed Lcl were determined bYe4
scan-
ing sacrifice, the lungs were excised and lavaged ning densitometry as described previously.
as described above.9 The major airways were
removed, then the parenchymal tissue was Statistics: Where appropriate, statistical analysis
blotted to remove excess moisture and weighed was performed using a Wilcoxon rank sum test
(wet weight). The weighed tissue was then for unpaired data. The level of significance was
minced and homogenized in a Waring blender p < 0.05.
with an equal mass of distilled water to give a
50% (w/w) homogenate which was divided into Rut
two equal portions. One half was placed in a
pre-weighed tube and the dry weight was deter- Macroscopic appearance: Lungs from rats given
mined by heating to 100C and re-weighing daily carrageenin alone (CARR) appeared mottled with
until no further weight loss occurred. The wet hard, lumpy areas. The lungs of all other animals
weight of I ml of autologous blood was mea- were macroscopically normal. The pleura
sured, then its dry weight was determined by the appeared normal in all animals.
same method.
The remaining half of each lung homogenate Histopathology: In pilot studies, no changes were
was centrifuged at 30000 x g at 4C for I h to seen at the light microscopic level 4 h after carra-
remove debris. The resulting supernatant was geenin instillation (Fig. lb). The peak effect of
assayed in duplicate for haemoglobin by the carrageenin (CARR) was observed 48h after
cyanmethaemoglobin method.
21 The haemoglob- instillation and consisted of large areas of inter-
in content of a sample of autologous whole stitial and intra-alveolar pneumonitis, with alveo-
blood from each rat was also quantified by the lar wall thickening and a prominent cellular
cyanmethaemoglobin method. The haematocrit infiltration (Fig. lc). By 96h after instillation,
was measured by centrifuging duplicate capillary there were fewer cells in airspaces and inter-
tubes of venous blood in a Hawksley micro- stitium, and the alveolar walls were less swollen;
centrifuge for 2 min and reading the percentage the inflammation appeared to be resolving
of cells on a calibrated scale. (Fig. ld). In pilot studies (data not shown) it was
The contribution of blood to the wet and dry found that a dose of 5mg carrageenin provoked
weights of each lung could then be calculated as the same inflammatory response at 48h post-
described previously,
22 except that haemoglobin instillation as 2.5 mg which we, therefore, believe
was used as a marker of blood. It was then pos- produces a maximal effect. Dexamethasone
sible to determine the blood-free lung water and alone (DEX: BASE DEX) had no effect on pul-
wet and dry lung weights. The haemoglobin monary histopathology at any of the time points
content of bronchoalveolar lavage, both fluid and examined (Fig. lf). In animals given both gluco-
cells, was also assessed but was below the limits corticoid and carrageenin (CARR+ DEX), there
of detection in all samples, was little alveolar wall thickening; however, the




FIG. 1. Light microscopy illustrating the evolution and resolution of the carrageenin-induced pneumonitis and the effect of dexa-
methasone. All sections are photographed at a magnification of x 38.
(a) Control (CON); (b) 4 h post-instillation of carrageenin; no significant changes seen; (c) 48 h post-instillation of carrageenin (CARR);
alveolar wall thickening and marked cellular infiltration; (d) 96 h post-instillation of carrageenin; fewer inflammatory cells in the air- and
interstitial spaces and less alveolar wall swelling than at 48 h; (e) dexamethasone-treated at 48 h after carrageenin instillation
(CARR+DEX); less alveolar wall swelling and fewer cells in the interstitium and airspaces than in rats given carrageenin alone at the




Bronchoalveolar lavage cell number and profile
and fluid recovery: The fluid recovery was
greater from animals given oral dexamethasone
for 48 h prior to sacrifice (BASE DEX, 49 --/-_ 3 ml,
mean _+ S.E.M.) than from those in any other
group (mean 4- S.E.M,; CON, 35 +__ 3 ml; DEX,
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35 4- 4 ml; CARR, 32 4- 5 ml; CARR+ DEX,
32 4-4ml). The total cell recoveries for each
group are shown in Fig. 2. In all but the animals
given both carrageenin and dexamethasone
(CARR+ DEX), the majority of cells in BALF were
alveolar macrophages (AM) and the remainder
polymorphonuclear neutrophils (PMN). Eosino-
phils were not detected in any lavage sample and
lymphocytes were rare. Instillation of carrageeninEffect ofdexamethasone in pneumonitis
16-












FIG. 2. Effect of treatment on total cell and polymorphonuclear
neutrophil numbers in bronchoalveolar lavage fluid. PMN, poly-
morphonuclear neutrophil; AM, alveolar macrophage; CON,
animals receiving no treatment; BASE DEX, animals given dexa-
methasone (10 mg/I) in drinking water for 48 h prior to sacri-
fice; DEX, animals given dexamethasone (10 mg/I) in drinking
water for 96 h prior to sacrifice; CARR, animals given 2.5 mg
carrageenin intratracheally and sacrificed 48 h later; CARR+DEX,
animals given dexamethasone for 48 h prior to carrageenin
exposure (2.5 mg intratracheally) and for a further 48 h after
carrageenin exposure, after which they were sacrificed.
a<CON; b>CON; c>DEX; d<CARR; e>CARR; in each
case, p < 0.05 in a Wilcoxon rank sum test for unpaired data.
Data expressed as means ___
standard error of mean; n 4.
Where no error bar is visible, the standard error is within the
diameter of the symbol.
(CARR) was associated with significant increases
in the total cell number; the majority of cells in
BALF were AM, although there was also a sig-
nifican increase in the number of PMN (Fig. 2).
Dexamethasone treatment for 48 h (BASE DEX)
had no effect on cell number or type (Fig. 2).
However, after 4 days of dexamethasone (DEX),
the total number of cells in BALF was reduced
compared with the untreated (CON) animals
(Fig. 2). Interestingly, whilst the total number of
cells in BALF from animals given carrageenin
plus dexamethasone (CARR+DEX) was inter-
mediate between those given either stimulus
alone, there were more PMN in their BAI than
in that of any other treatment group (Fig. 2),
indicating that the dexamethasone had selectively
suppressed the AM infiltration. The mean
number of AM/g wet tissue following various
treatments was as follows: CON, 4.02 x 106/g;
BASE DEX, 2.58 x 106/g; DEX, 1.58 x 106/g;
CARR,, 11.35 x 106/g; CARR+ DEX, 2.87 x 106/g.
Orculating white blood cells: The blood smears
indicated that carrageenin had no effect on the
differential white blood cell ratios at any time
point (CON 9___ 2% polymorphs, CARR
16 _+ 3% polymorphs, mean + S.E.M., n 6 per
group, p > 0.05). In rats treated with dexa-
methasone, or carrageenin and dexamethasone,
most of the circulating leucocytes were poly-
morphs (DEX 74 +_ 2%; CARR+DEX
83 +_ 3%). This change in differential count was
due to a substantial reduction in the number of
circulating mononuclear cells; the number of cir-
culating PMN fell by a lesser amount in response
to exogenous glucocorticoid.
Electron microscopy: Following carrageenin instil-
lation (CARR), the alveolar spaces contained large
numbers of foamy AM, some containing particles
(probably carrageenin) in vacuoles (Fig. 3a).
PMN were also observed. In addition, the alveolar
spaces contained many round bodies, usually
devoid of organelles and thus, appearing com-
paratively electron-lucent (Fig. 3a). Similar struc-
tures were associated with some Type II alveolar
epithelial cells and high magnification revealed
continuity between the organelle-rich cell cyto-
plasm and the electron-lucent bulge (Fig. 3b),
indicating that the bodies probably originated
from the Type II cells. Type II cells were present
in increased numbers, often several in close
proximity (Fig. 3a). Damage to alveolar Type I
cells was common (Fig. 3b). Occasionally, lengths
of basement membrane denuded of epithelium
were seen; these were associated with areas of
interstitial oedema (Figs 3c and 3d). There was
also evidence of endothelial damage, with shrink-
ing and increased cell density (Fig. 3d). An
increase in interstitial collagen was observed.
By comparison, the changes were minor in the
lungs of rats given carrageenin plus dexa-
methasone (CARR+DEX). There was a slight
increase in the number ofAM compared with the
control groups, and occasional swelling of the
Type I epithelial cells was seen (Fig. 1; EM not
shown). No difference was seen between groups
given dexamethasone alone (DEX) and untreated
controls (CON), all of which appeared normal
(Fig. 1; EM not shown).
Assessment of oedema by wet and dry lung
weights: In untreated rats, approximately 90% of
the total lung weight (excluding blood) was
water. Carrageenin treatment alone (CARR)
resulted in significant increases in lung water and
dry lung weight compared with the control and
those given glucocorticoid alone (DEX and BASE
DEX; Table 1). The total amount of blood in
carrageenin-treated lungs (CARR) was unchanged
compared with the control (CON; Table 1), but
because of the increased lung weight, blood
represented only 6% of the total wet weight
rather than 12% as in the controls (Table 1).
Glucocorticoid administration significandy re-
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FIG. 3. Electron micrographs of lung sections from rats treated with carrageenin alone (CARR) and sacrificed 48 h after instillation. In
each figure, the bar represents 10 microns unless otherwise stated. (a) Many foamy macrophages (m) and an electron lucent round
body (rb) in the alveolar space; also in the section are two Type II epithelial cells (11) in close proximity (magnification x 2 000). (b) A
Type II epithelial cell from which protrudes a bulbous extension; high magnification (x 20000) confirms cytoplasmic continuity with
the Type II cell. The section also shows a damaged, vacuolated Type (I) cell (magnification of main picture x 5 000). (c) Interstitial
oedema (o) in close proximity to a region of denuded epithelial basement membrane (arrows), part of which (A) is shown at higher
magnification in Fig. 3(d) (magnification x 2 700). (d) Fragments of epithelium associated with a length of denuded basement mem-
brane (arrow). Note also abnormal capillary endothelium (en) with increased density and cell shrinkage (magnification x 28000; the
bar represents micron).
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Table 1. Wet and dry lung and lung blood weights
Group/ n Wet lung wt (mg) Dry lung wt (mg) Lung blood Lung blood
treatment (excluding wt of lung blood) wet wt (mg) (% total lung wet wt)
CON 6 995 _-+ 51
b 116 -t- 9
b 124 +_ 8 11.3 +__ 2.4
BASE DEX 7 806 +_ 34 107 + 5 102 9 11.4 -t- 3.2
DEX 6 705 -t- 24 89 __+ 12 93 4 11.7 +__ 1.5
CARR 6 1881 +__ 198 231 +__ 24 110-I- 19 5.9 __+ 3.1
CARR+DEX 7 1144 __+ 83 123 __+ 9
b 107 -t-_ 15 8.5 -i- 2.1
d
CON, animals receiving no treatment;
BASE DEX, animals given dexamethasone (10 mg/I) in drinking water for 48 h prior to sacrifice;
DEX, animals given dexamethasone (10 mg/I) in drinking water for 96 h prior to sacrifice;
CARR, animals given 2.5 mg carrageenin intratracheally and sacrificed 48 h later;
CARR+DEX, animals given dexamethasone for 48 h prior to carrageenin exposure (2.5 mg intratracheally) and for a further 48 h
after carrageenin exposure, after which they were sacrificed.
Data represent mean -t- standard error of the mean; < CON; > DEX; > all other groups; < DEX; p < 0.05 in a Wilcoxon
Rank Sum Test.
duced the lung water within 48h (BASE DEX;
Table 1) and the dry lung weight by 96 h (DEX).
There was less blood in glucocorticoid-treated
lungs (DEX) compared with the controls (CON;
Table 1), but as a percentage of the total wet
lung weight, it was unchanged (11-12%). The
lungs of animals given both glucocorticoid and
carrageenin (CARR+ DEX) were intermediate
between those given either stimulus alone, in
terms of dry lung weight and lung water, and did
not differ from controls (CON; Table 1). Like-
wise, the amount of blood in the lungs of rats
given both carrageenin and dexamethasone
(CARR+ DEX) was not significantly different to
any other group, but as a percentage of total
lung weight, it was intermediate between carra-
geenin-treated animals (CARR) and those in the
other treatment groups.
Extracellular lipocortin 1 in bronchoalveolar
lavage fluid.. Lcl was detected by ELISA in BALF
from all the animals investigated. Approximately
90% of the Lcl in BAI from control (CON) rats
was intact, as determined by Western blotting.
Treatment with dexamethasone for 48h (BASE
DEX) or 96h (DEX) was associated with a
doubling of total Lcl in BALF, which again, was
over 90% intact. Carrageenin-treated rats (CARR)
also had twice as much Lcl in their BALF as
controls, but over half of it was in the proteo-
lysed form (Fig. 4). When both glucocorticoid
and irritant were administered to the same
animals (CARR+DEX), the total Lcl concentra-
tion was approximately 10 times the control
levels and was significantly greater than all the
other treatments. However, as only 15% of this
Lcl was in its intact form, the concentration of
intact Lcl did not differ significantly from any
other treatment group (Fig. 4). None of these
changes could be explained by changes in BAL
volume.
Discussion
This study describes some of the morphologi-
cal, cellular and biochemical changes occurring in
the rodent lung following the intratracheal instilla-
tion of carrageenin. We observed an inflammatory
response which was maximal at 48 h post-instilla-
tion and which was characterized by interstitial
oedema and an influx of macrophages and PMN.
Prior administration of an exogenous glucocorti-
coid greatly reduced the inflammation, confirming
250
a
200- Total Lcl ng/ml BALF
Intact Lcl ng/ml BALF
150-
FIG. 4. Effect of treatment on total and intact extracellular lipo-
cortin concentration in bronchoalveolar lavage fluids. CON,
animals receiving no treatment; BASE DEX, animals given dexa-
methasone (10 mg/I) in drinking water for 48 h prior to sacri-
fice; DEX, animals given dexamethasone (10 mg/I)in drinking
water for 96 h prior to sacrifice; CARR, animals given 2.5 mg
carrageenin intratracheally and sacrificed 48 h later; CARR+DEX,
animals given dexamethasone for 48 h prior to carrageenin
exposure (2.5 mg intratracheally) and for a further 48 h after
carrageenin exposure, after which they were sacrificed.
atotal Lcl/ml > CON; bintact Lcl/ml > CON; in each case,
p < 0.05 in a Wilcoxon rank sum test for unpaired data. Data
expressed as means -t-_ standard error of mean; n 4. Where no
error bar is shown, the error is within the diameter of the symbol.
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the hypothesis that carrageenin is essentially inert that a major effect of the glucocorticoids is to
if the inflammatory response is subdued. Further- down-regulate the actions of these cells.
more, dexamethasone was associated with an One of the most intriguing features of the
increase in extracellular levels of Lcl, an anti- current model is that whilst the epithelial damage
inflammatory protein which may contribute to the and interstitial oedema caused by carrageenin
actions of the glucocorticoid, was clearly prevented by dexamethasone admin-
Historically, carrageenin has been used to istration, this effect was accompanied by sig-
provoke an inflammatory response in a wide nificant increases in both the number and
range of tissues, including the lungs of rabbits, percentage of lung PMN. This was observed
cats and rodents.24-26 The effects of carrageenin despite the reduced number of circulating leuko-
on lung morphology in this study are similar to cytes and suggests that either the cells were
those reported previously,25’27-3 namely, an early actively recruited into the lung (by changes in
infiltration of PMN and macrophages, many of chemotaxins or adhesion molecules) or were not
which phagocytosed carrageenin particles, plus cleared, perhaps because the PMN did not
epithelial cell damage and basement membrane become apoptotic or because the reduced
denudation, followed by Type II cell hyperplasia, number of macrophages prevented removal of
We have not found specific reference to the car- apoptotic PMN. The data further suggest that
rageenin-induced emergence of electron-lucent once inflammation is established, the PMN is less
’blebs’ from Type II cells described in the deleterious than initially. There is some evidence
current investigation. However, such a phenom- to support this view, suggesting that PMN may
enon has been described in a clinical context in play a subtle role in modulation of the inflamma-
a case of Type II cell adenocarcinoma and thus, tory and immune responses, and may even
is not necessarily a specific response to carragee- promote mechanisms of repair (reviewed in
nin,
3 but may be a nonspecific effect associated Reference 1). In addition, there is evidence that
with epithelial cell damage and hyperplasia. In PMN are activated by cytokines and growth
addition to confirming the morphological obser- factors released from monocytes and macro-
vations of previous authors, we have demon- phages such as GM-CSF and TNF. Hence, gluco-
strated that the response to carrageenin can be corticoids may reduce PMN activity in the lung
suppressed by pretreatment with dexamethasone, directly (for .example, as indicated in Reference
In this study we found no change in the 34) or indirectly by reducing both the number of
profile of circulating white cells after intratracheal macrophages (Fig. 2) and their ability to release
carrageenin. This is in contrast to intraperitoneal mediators which stimulate PMN.35
administration in which there is a marked We hypothesize that the protective effect of
increase in the number of circulating PMN prob- the glucocorticoids may be due in part to the
ably due to increased release from the bone increase in extracellular Lcl observed in this
marrow, perhaps combined with the lack of study. Lcl probably exerts its anti-inflammatory
alternative routes of cell clearance from the peri- activity by binding to cell surface receptors.
1
toneal cavity
32 and a decline in monocytes. The increase in extracellular Lcl observed in
Although an increase in oedema has been response to dexamethasone ma have been
observed within 2- 3 h after carrageenin in the caused by de novo Lcl synthesis, translocation
rat paw,
1 in the lung we saw no morphological to the cell surface36 or a combination of both,
evidence of oedema at 4h. However, by 48h and may have resulted in enhanced Lcl activity
interstitial oedema was visible by EM (Fig. 3) and within the lung. Interestingly, carrageenin admin-
lung water was markedly increased (Table 1). istration was also associated with an increase in
Dexamethasone administration prevented the Lcl in the epithelial lining fluid. We cannot
interstitial oedema and the accompanying epithel- exclude the possibility that carrageenin induced
ial damage and was also associated with a decline Lcl indirectly, by stimulating a rise in circulating
in macrophage numbers in the lung. This is in corticosterone. However, inflammatory stimuli
keeping with the findings of Heluy-Neto et al.33 such as paraffin oil
8 and endotoxin3v have been
who studied the effects of glucocorticoid deple- shown to cause increases in Lcl in glucocorti-
tion (by adrenalectomy) on carrageenin-induced coid-depleted (adrenalectomised) rats, so it is
inflammation of the pleura, and reported that possible that the increase was a direct effect of
both the number of monocytes and the inflam- the inflammogen on resident or inflammatory
matory exudate in the pleural cavity increased cells. In carrageenin-treated animals, the pre-
more following an adrenalectomy than a sham dominant form of Lcl was a 34kDa species
operation. Thus, together, these studies suggest which lacks the N-terminal believed to confer
that the activity of activated monocytes may cause functional specificity
6 and which was probably.
oedema and exacerbate the inflammation, and clipped by the action of neutrophil elastase.
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Reduction of intact Lcl by proteolysis may feed-
back to stimulate further Lcl synthesis and/or
release, and this may explain the apparent
synergy between carrageenin and dexamethasone
with regard to extracellular Lcl levels; the two
stimuli may have increased extracellular Lcl by
different mechanisms. Although functional Lcl
was markedly reduced in the epithelial lining
fluid of rats given carrageenin only, prior and
concurrent administration of dexamethasone
maintained intact (functional) extracellular Lcl at
the control level. The very high level of total Lcl
in animals given glucocorticoid and inflammogen
suggests that release of this protein in its
functional form earlier in the response may have
contributed to the protective effect of dexa-
methasone. The anti-inflammatory mechanisms of
tcl are complex and incompletely understood,
but may include a dose-dependent reduction in
interactions between IgG and Fc, receptors on
PMN and monocytes, an effect which may
reduce the oxidant-producing capacity and other
pro-inflammatory functions of these cells.
In summary, in this study we have used a
model of carrageenin-induced pulmonary inflam-
mation to investigate the possible anti-inflamma-
tory mechanisms of action of dexamethasone. We
conclude that an increase in extracellular Lcl may
be one mechanism by which this synthetic gluco-
corticoid controls pulmonary inflammation.
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